Postnatal betamethasone vs dexamethasone in premature infants with bronchopulmonary dysplasia: A pilot study

Journal of Perinatology

Volumn 29, Issue 4, 2009, Pages 297-304

  DeCastro, M ^a   El Khoury, N ^b   Parton, L ^a   Ballabh, P ^a   LaGamma, E F ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

^b SUNY Downstate Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETAMETHASONE; DEXAMETHASONE; OXYGEN;

AIRWAY PRESSURE; ARTICLE; ARTIFICIAL VENTILATION; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; ENCEPHALOMALACIA; EXTUBATION; FEMALE; GESTATIONAL AGE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; LENGTH OF STAY; LOW DRUG DOSE; LUNG DYSPLASIA; MALE; NEWBORN; PERINATAL PERIOD; PILOT STUDY; PREMATURITY; SEPSIS; SHORT COURSE THERAPY; SIDE EFFECT; SYSTOLIC BLOOD PRESSURE; TREATMENT DURATION; WEANING; WEIGHT GAIN;

ANTI-INFLAMMATORY AGENTS; BETAMETHASONE; BRONCHOPULMONARY DYSPLASIA; DEXAMETHASONE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; INFANT, EXTREMELY LOW BIRTH WEIGHT; INFANT, NEWBORN; INFUSIONS, INTRAVENOUS; INJECTIONS, INTRAMUSCULAR; LENGTH OF STAY; MALE; OXYGEN; PILOT PROJECTS; VENTILATOR WEANING;

EID: 63649109906     PISSN: 07438346     EISSN: 14765543     Source Type: Journal    
DOI: 10.1038/jp.2008.194     Document Type: Article

References (39)

1. Groneck P, Gotze-Speer B, Oppermann M, Eiffert H, Speer CP. Association of pulmonary inflammation and increased microvascular permeability during the development of bronchopulmonary dysplasia: A sequential analysis of inflammatory mediators in respiratory fluid of high risk preterm neonates. Pediatrics 1994; 93: 712-718.
2. Pierce MR, Bancalari E. The role of inflammation in the pathogenesis of bronchopulmonary dysplasia. Pediatr Pulmonol 1995; 19: 371-378.
3. Halliday HL, Ehrenkranz RA, Doyle LW. Delayed (>3 Weeks) Postnatal Corticosteroids for Chronic Lung Disease in Preterm Infants (Cochrane Review). The Cochrane Library, Issue 2, 2005. Wiley: Chichester, UK.
4. Halliday HL, Ehrenkranz RA, Doyle LW. Moderately Early (7-14 Days) Postnatal Corticosteroids for Preventing Chronic Lung Disease in Preterm Infants (Cochrane Review). The Cochrane Library, Issue 2, 2005. Wiley: Chichester, UK.
5. Halliday HL, Ehrenkranz RA, Doyle LW. Early Postnatal (<96 Hours) Corticosteroids for Preventing Chronic Lung Disease in Preterm Infants (Cochrane Review). The Cochrane Library, Issue 2, 2005. Wiley: Chichester, UK.
6. Grier DG, Halliday HL. Management of BPD: Guidelines for corticosteroid use. Drugs 2005; 66(1): 15-29.
7. American Academy of Pediatrics, Committee on Fetus and Newborn and Canadian Paediatric Society, Fetus and Newborn Committee. Postnatal corticosteroids to treat or prevent chronic lung disease in preterm infants. Pediatrics 2002; 109: 330-338.
8. Taylor C, Shah P, Dunn M. Meta-analysis of postnatal steroid use challenged. Pediatrics 2002; 109: 716-717.
9. Jacobs HC, Chapman RL, Gross I. Premature conclusions on postnatal steroid effects. Pediatrics 2002; 110: 200-201.
10. Soll RF. Corticosteroids for the treatment & prevention of BPD. Acta Paediatr 2003; 92: 886-889.
11. Ruffert P, Pmpana JP, Breart G, Saugstad OD, Goelz R, Halliday HL et al. Treatment strategies for BPD with postnatal corticosteroids in Europe: The EURAIL survey. Acta Paediatr 2003; 92: 948-951.
12. Jobe AH. Glucocorticoids, inflammation and the perinatal lung. Semin Neonatol 2001; 6: 331-342.
13. Mathews SG. Antenatal glucocorticoids and the developing brain: mechanisms of action. Semin Neonatol 2001; 6: 309-317.
14. Whitelaw A, Thoresen M. Antenatal steroids and the developing brain. Arch Dis Child Fetal Neonatal Ed 2000; 83: F154-F157.
15. Abraham I, Harkany T, Hovath KM, Veenema AH, Penke B, Nyakas C et al Chronic corticosterone administration dose dependency modulates Ab(1-42) and NMDA induced neurodegeneration in rat magnocellular nucleus basalis. J Neuroendocrinol 2000; 12: 486-494.
16. Baud O, Fiox-L'Helias L, Kaminski M, Audibert F, Jarreau PH, Papiernik E et al. Antenatal glucocorticoid treatment and cystic periventricular leukomalacia in very premature infants. N Engl J Med 1999; 341: 1190-1196.
17. Trenque T, Lamiable D, Vistelle R, Millart H, Leterre A, Choisy H. Comparative pharmacokinetics of two diasteroisomers dexamethasone and betamethasone in plasma and cerebrospinal fluid in rabbits. Fundam Clin Pharmacol 1994; 8: 430-436.
18. Alderson AL, Novack TA. Neurophysiological and clinical aspects of glucocorticoids and memory: A review. J Clin Exp Neuropsychol 2002; 24: 335-355.
19. Christensen HD, Sienko AE, Rayburn WF, Gonzalez CL, Coleman FH. A placebo controlled, blinded comparison between betamethasone and dexamethasone to enhance lung maturation in fetal mouse. J Soc Gynecol Invest 1997; 4: 130-134.
20. Löhle M, Müller T, Wicher C, Roedel M, Schubert H, Witte OW et al. Betamethasone effects on fetal sheep cerebral blood flow are not dependent on maturation of cerebrovascular system and pituitary-adrenal axis. J Physiol 2005; 564(Part 2): 575-588.
21. Cambonie G, Mesnage R, Milési C, Pidoux O, Veyrec C, Picaud JC. Betamethasone impairs cerebral blood flow velocities in very premature infants with severe chronic lung disease. J Pediatr 2008; 152 2): 270-275.
22. La Gamma EF, Browne LE. Feeding practices for infants weighing less than 1500 g at birth and the pathogenesis of necrotizing enterocolitis. Clinics Perinatol 1994; 21: 271-306.
23. Brumberg H, La Gamma EF. Nutrition: Enhance outcomes for premature infants. Pediatr Ann 2003; 32(9): 617-625.
24. Mishra R, Golombek SG, Ramirez-Tolentino SR, Das S, La Gamma EF. Low-birth-weight neonates exhibit a physiological set-point to regulate CO2: An untapped potential to minimize volutrauma-associated lung injury. Am J Perinatol 2003; 20: 453-463.
25. Zia M, Mishra R, Hassan M, LaGamma EF. Optimal FRC approach to hyaline membrane disease and its effects on chronic lung disease. Pediatr Res 2002; 51940: 2279A.
26. Durand M, Mendoza ME, Tantivit P, Kugelman A, McEvoy C. A randomized trial of moderately early low-dose dexamethasone therapy in very low birth weight infants: Dynamic pulmonary mechanics, oxygenation, and ventilation. Pediatrics 2002; 109: 262-268.
27. Charles B, Schild P, Steer P, Cartwright D, Donovan T. Pharmacokinetics of dexamethasone following single-dose intravenous administration to extremely low birth weight infants. Dev Pharmacol Ther 1993; 20 205-210.
28. Ballard PL, Ballard RA. Scientific basis and therapeutic regimens for use of antenatal glucocorticoids. Am J Obstet Gynecol 1995; 173 254-262.
29. Lemons JA, Bauer CR, Oh W, Korones SB, Papile LA, Stoll BJ et al. Very low birth weight outcomes of National Institutes of Child Health and Human Development Neonatal Research Network, January 1995 through December 1996. Pediatrics 2001; 107, Available at: http://www.pediatrics.org/cgi/content/full/107/1/e1.
30. Baraldi E, Filippone M. Chronic lung disease after premature birth. N Engl J Med 2007; 357(19): 1946-1955.
31. Aly H. Mechanical ventilation and cerebral palsy. Pediatrics 2005; 115: 1765-1767.
32. Bhuta T, Ohlsson A. Systemic review and meta-analysis of early postnatal dexamethasone for prevention of chronic lung disease. Arch Dis Child Fetal Neonatal Ed 1998; 79: F26-F33.
33. Arias-Camison JM, Lau J, Cole CH, Frantz III ID. Meta-analysis of dexamethasone therapy started in first 15 h of life for prevention of chronic lung disease in premature infants. Pediatr Pulmonol 1999; 28: 167-174.
34. Doyle L, Davis P. Postnatal corticosteroids in preterm infants: systematic review of effects on mortality and motor function. J Pediatr Child Health 2000; 36: 101-107.
35. Lee BH, Stoll BJ, McDonald SA, Higgins RD, for National Institute of Child Health and Human Development Neonatal Research Network. Neurodevelopmental outcomes of extremely low birth weight infants exposed prenatally to dexamethasone versus betamethasone. Pediatrics 2008; 121(2): 289-296.
36. Uno H, Eisele S, Sakai A, Shelton S, Baker E, DeJesus O et al. Neurotoxicity of glucocorticoids in primate brain. Horm Behav 1994; 28: 336-348.
37. Uno H, Lohmiller L, Thieme C, Kemnitz JW, Engle MJ, Recker EB et al Brain damage induced by prenatal exposure of dexamethasone in fetus rhesus macaques: I. Hippocampus. Dev Brain Res 1990; 53: 157-167.
38. Doyle LW, Gavis PG, Morley CJ, McPhee A, Carlin JB, and the DART Study Investigators. Pediatr 2006; 117(1): 75-83.
39. Doyle LW, Gavis PG, Morley CJ, McPhee A, Carlin JB, and the DART Study Investigators. Pediatr 2007; 119(4): 716-721.